Clinical Trial

Preoperative Risk Stratification in Endometrial Cancer for Tailoring Lymph Node Staging

Study acronym: PRSTEC_multipr
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluaty the accuracy of current risk stratification of patients with endometrial cancer and to redefine lymph node staging recommendations based on real-world clinical data. The main question it aims to answer is: Is there any group of patients who doesn't need lymph node staging for proper indication of adjuvant treatment? Participants are note taking any intervention. They are treated according to current standard of care and followed 3-years after primary surgery.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-23
Trial Details
NCT Number NCT07368205
Lead Sponsor University Hospital Hradec Kralove
Conditions Endometrial Cancer
Enrollment 350 participants
Start Date 2026-02-15
Primary Completion 2028-02 (estimated)
Study Completion 2031-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-22